252 related articles for article (PubMed ID: 15367431)
1. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance.
Kobayashi H; Dubois S; Sato N; Sabzevari H; Sakai Y; Waldmann TA; Tagaya Y
Blood; 2005 Jan; 105(2):721-7. PubMed ID: 15367431
[TBL] [Abstract][Full Text] [Related]
2. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
3. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
[TBL] [Abstract][Full Text] [Related]
4. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Rowley J; Monie A; Hung CF; Wu TC
J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
[TBL] [Abstract][Full Text] [Related]
6. Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions.
Ullrich E; Bonmort M; Mignot G; Jacobs B; Bosisio D; Sozzani S; Jalil A; Louache F; Bulanova E; Geissman F; Ryffel B; Chaput N; Bulfone-Paus S; Zitvogel L
J Immunol; 2008 Jun; 180(12):7887-97. PubMed ID: 18523252
[TBL] [Abstract][Full Text] [Related]
7. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation.
Castillo EF; Stonier SW; Frasca L; Schluns KS
J Immunol; 2009 Oct; 183(8):4948-56. PubMed ID: 19786554
[TBL] [Abstract][Full Text] [Related]
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
10. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
Kawamura T; Koka R; Ma A; Kumar V
J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
[TBL] [Abstract][Full Text] [Related]
11. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.
Koka R; Burkett P; Chien M; Chai S; Boone DL; Ma A
J Immunol; 2004 Sep; 173(6):3594-8. PubMed ID: 15356102
[TBL] [Abstract][Full Text] [Related]
13. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
Mortier E; Woo T; Advincula R; Gozalo S; Ma A
J Exp Med; 2008 May; 205(5):1213-25. PubMed ID: 18458113
[TBL] [Abstract][Full Text] [Related]
14. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
15. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
[TBL] [Abstract][Full Text] [Related]
16. An antibody fusion protein for cancer immunotherapy mimicking IL-15 trans-presentation at the tumor site.
Kermer V; Baum V; Hornig N; Kontermann RE; Müller D
Mol Cancer Ther; 2012 Jun; 11(6):1279-88. PubMed ID: 22491823
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
Gillgrass AE; Chew MV; Krneta T; Ashkar AA
BMC Cancer; 2015 Apr; 15():293. PubMed ID: 25879689
[TBL] [Abstract][Full Text] [Related]
18. Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells.
Jungraithmayr W; Codarri L; Bouchaud G; Krieg C; Boyman O; Gyülvészi G; Becher B; Weder W; Münz C
Am J Respir Crit Care Med; 2013 Jun; 187(12):1349-59. PubMed ID: 23590269
[TBL] [Abstract][Full Text] [Related]
19. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
20. Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation.
Perdreau H; Mortier E; Bouchaud G; Solé V; Boublik Y; Plet A; Jacques Y
Eur Cytokine Netw; 2010 Dec; 21(4):297-307. PubMed ID: 21078585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
